Sep 13, 2012
Global natural health and beauty products company Comvita has a major presence at The University of Auckland through the co-location of its research company Comvita Innovation in the IIB and collaborations with a number of departments. At its annual flagship event, the Comvita Science Symposium held on 6th September, the company announced a clinical trial by The Liggins Institute at The University of Auckland has shown fresh olive leaf extract prepared by Comvita, improves the way insulin is secreted and works in overweight men. Insulin that does not work effectively can lead to diabetes.
The randomised, double-blinded, placebo-controlled cross-over trial was undertaken by 47 middle-aged and overweight men at risk of developing type-2 diabetes, a disorder characterised by insulin resistance and deficiency.
The Liggins Institute Director and Principal Investigator Professor Wayne Cutfield and Clinical Research Fellow Dr Martin de Bock assessed a range of complex health outcomes including insulin responses among those trial participants who took fresh olive leaf extract for 12 weeks.
Comvita CEO Brett Hewlett said Comvita is very pleased with the results, which have been submitted by The Liggins Institute for peer review and publication, to a highly prestigious, international medical journal.
“Due to restrictions around the submission process to the medical journal, further details from the trial can only be discussed after the results have been published.”
“However, we expect there will be increased interest in Comvita products as a result of the trial. We’re also scoping the possibility of building on this science, with additional clinical trials.”
“The study underscores the potential for efficacious, proven natural products to play an integral role in improving health outcomes.”
This important piece of research was made possible through collaboration with The Ministry of Business Innovation and Employment’s (MBIE) Science + Innovation Group.